Lanzamiento Enero 2027

Ensayo clínico controlado2018Financiado por la industria

Financiado en parte por GlaxoSmithKline, GlaxoSmithKline (GSK)

Creatine ( methyl-d3) dilution in urine for estimation of total body skeletal muscle mass: accuracy and variability vs. MRI and DXA

Clark RV, Walker AC, Miller RR, O'Connor-Semmes RL, Ravussin E, Cefalu WT

Journal of applied physiology (Bethesda, Md. : 1985) · 56 citas

Etiquetas de revisión

Financiado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo clínico controlado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiado por la industria
Empresa
GlaxoSmithKline
Gobierno
National Institute of Diabetes and Digestive and Kidney Diseases
Empresa
GlaxoSmithKline (GSK)
Gobierno
NIDDK NIH HHS
Subvenciones
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-072476)

Según 4 financiadores declarados.

Publicación

Publicado
2017-08-31 · J Appl Physiol (1985) · vol. 124 · número 1 · págs. 1–9
Editorial
American Physiological Society
Citado
67 citas · más que el 88% de estudios similares · 2.3× el promedio de su campo
Referencias
32 trabajos
Acceso
Acceso abierto (copia en repositorio)
Áreas de investigación
Muscle metabolism and nutrition · Nutrition and Health in Aging · Body Composition Measurement Techniques
Palabras clave
Creatine, Creatinine, Urine, Lean body mass, Medicine, Dual-energy X-ray absorptiometry, Internal medicine, Endocrinology, Body weight, Bone mineral
MeSH
muscle, skeletal, humans, deuterium, creatine, magnetic resonance imaging, absorptiometry, photon, indicator dilution techniques, body composition, aged, aged, 80 and over, middle aged, female, male

6 autores

  • Richard V. Clark🇺🇸 · autor de correspondenciaResearch Triangle Park Foundation; GlaxoSmithKline (United States)
  • Ann C. Walker🇺🇸Research Triangle Park Foundation; GlaxoSmithKline (United States)
  • Ram R. Miller🇺🇸Research Triangle Park Foundation; GlaxoSmithKline (United States)
  • Robin L. O'Connor‐Semmes🇺🇸Research Triangle Park Foundation; GlaxoSmithKline (United States)
  • Éric Ravussin🇺🇸Pennington Biomedical Research Center
  • William T. Cefalu🇺🇸Pennington Biomedical Research Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

A noninvasive method to estimate muscle mass based on creatine ( methyl-d3) (D3-creatine) dilution using fasting morning urine was evaluated for accuracy and variability over a 3- to 4-mo period. Healthy older (67- to 80-yr-old) subjects ( n = 14) with muscle wasting secondary to aging and four patients with chronic disease (58-76 yr old) fasted overnight and then received an oral 30-mg dose of D3-creatine at 8 AM ( day 1). Urine was collected during 4 h of continued fasting and then at consecutive 4- to 8-h intervals through day 5. Assessment was repeated 3-4 mo later in 13 healthy subjects and 1 patient with congestive heart failure. Deuterated and unlabeled creatine and creatinine were measured using liquid chromatography-tandem mass spectrometry. Total body creatine pool size and muscle mass were calculated from D3-creatinine enrichment in urine. Muscle mass was also measured by whole body MRI and 24-h urine creatinine, and lean body mass (LBM) was measured by dual-energy X-ray absorptiometry (DXA). D3-creatinine urinary enrichment from day 5 provided muscle mass estimates that correlated with MRI for all subjects ( r = 0.88, P 3-creatine dilution method, with intrasubject SD for estimated muscle mass of 2.5 kg vs. MRI (0.5 kg) and DXA (0.8 kg). This study supports further clinical validation of the D3-creatine method for estimating muscle mass. NEW & NOTEWORTHY Measurement of creatine ( methyl-d3) (D3-creatine) and D3-creatinine excretion in fasted morning urine samples may be a simple, less costly alternative to MRI or dual-energy X-ray absorptiometry (DXA) to calculate total body muscle mass. The D3-creatine enrichment method provides estimates of muscle mass that correlate well with MRI, and with less bias than DXA. However, intraindividual variability is high with the D3-creatine method. Studies to refine the spot urine sample method for estimation of muscle mass may be warranted.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.